Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Clinical and Experimental Rheumatology|August 31, 2023
Comorbidities in the Spondyloarthritis GISEA Cohort: an average treatment effect analysis on patients treated with bDMARDsLaura Scagnellato, Antonio Collesei, Andrea Doria, et al.
Joint Bone Spine|May 23, 2017
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritisMarco Sebastiani, Fabiola Atzeni, Laura Milazzo, et al.
Clinical Rheumatology|May 22, 2016
Adult-onset Still's disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patientsPaolo Sfriso, Roberta Priori, Guido Valesini, et al.
Joint Bone Spine|August 7, 2020
Golimumab effectiveness in biologic inadequate responding patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis in real-life from the Italian registry GISEAFlorenzo Iannone, Ennio G Favalli, Roberto Caporali, et al.
Clinical and Experimental Rheumatology|November 30, 2017
Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritisMassimo Galli, Spinello Antinori, Fabiola Atzeni, et al.
Modern Rheumatology|December 25, 2018
Italian consensus recommendations for the management of hepatitis C infection in patients with rheumatoid arthritisMarco Sebastiani, Laura Milazzo, Fabiola Atzeni, et al.
Joint Bone Spine|August 2, 2014
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA registerMarco Sebastiani, Maria Grazia Anelli, Fabiola Atzeni, et al.
Frontiers in Pharmacology|June 30, 2017
Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational StudySerena Colafrancesco, Roberta Priori, Guido Valesini, et al.
Frontiers in Pharmacology|April 20, 2019
Long-Term Retention Rate of Anakinra in Adult Onset Still's Disease and Predictive Factors for Treatment ResponseAntonio Vitale, Giulio Cavalli, Serena Colafrancesco, et al.
Frontiers in Pharmacology|November 9, 2016
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational StudyAntonio Vitale, Antonella Insalaco, Paolo Sfriso, et al.
Pageof 12